文献速递肝病消化道肿瘤与早癌

肠道微生物组、宿主遗传与表观遗传修饰在MASLD及MASLD相关肝细胞癌中的相互作用

Interplay between gut microbiome, host genetic and epigenetic modifications in MASLD and MASLD-related hepatocellular carcinoma.
PubMed 文献 · Gut · 2024-12-10

本文综述肠道微生物组、宿主遗传与表观遗传改变在代谢功能障碍相关脂肪性肝病(MASLD)及MASLD相关肝细胞癌(MASLD-HCC)中的作用,并讨论肠道微生物组与宿主遗传/表观遗传之间双向影响的研究发现,强调这种相互关联在MASLD预防和治疗中的意义。

要点

  • 宿主遗传影响肠道微生物组组成,肠道微生物群及其衍生代谢物可诱导宿主表观遗传修饰。
  • 肠道微生物组与宿主遗传/表观遗传的双向影响在MASLD及MASLD-HCC中具有重要意义。
  • 探索肠道微生物组与宿主遗传/表观遗传的复杂关系有望为MASLD及其相关疾病的治疗干预提供新途径。

核心结论

  • 肠道微生物组与宿主遗传/表观遗传之间存在双向影响,这种相互关联在MASLD预防和治疗中具有重要意义。
  • 探索肠道微生物组与宿主遗传/表观遗传的复杂关系有望为针对MASLD及其相关疾病的治疗干预提供有前景的途径。

研究设计与样本

  • 本文为综述,总结肠道微生物组、宿主遗传与表观遗传改变在MASLD及MASLD-HCC中的作用。

主要发现

  • 宿主遗传影响肠道微生物组组成。
  • 肠道微生物群及其衍生代谢物可诱导宿主表观遗传修饰,从而影响MASLD的发展。
  • 研究证据显示肠道微生物组与宿主遗传/表观遗传之间存在双向影响。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Metabolic dysfunction-associated steatotic liver disease (MASLD) encompasses a wide spectrum of liver injuries, ranging from hepatic steatosis, metabolic dysfunction-associated steatohepatitis (MASH), fibrosis, cirrhosis to MASLD-associated hepatocellular carcinoma (MASLD-HCC). Recent studies have highlighted the bidirectional impacts between host genetics/epigenetics and the gut microbial community. Host genetics influence the composition of gut microbiome, while the gut microbiota and their derived metabolites can induce host epigenetic modifications to affect the development of MASLD. The exploration of the intricate relationship between the gut microbiome and the genetic/epigenetic makeup of the host is anticipated to yield promising avenues for therapeutic interventions targeting MASLD and its associated conditions. In this review, we summarise the effects of gut microbiome, host genetics and epigenetic alterations in MASLD and MASLD-HCC. We further discuss research findings demonstrating the bidirectional impacts between gut microbiome and host genetics/epigenetics, emphasising the significance of this interconnection in MASLD prevention and treatment.

来源:Gut,查看原文。版权归原作者所有。

引用

  1. Ha S, Wong VW, Zhang X, et al. Interplay between gut microbiome, host genetic and epigenetic modifications in MASLD and MASLD-related hepatocellular carcinoma. Gut. 2024. PMID: 38950910. doi:10.1136/gutjnl-2024-332398

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。